Action BMY BRISTOL-MYERS SQUIBB COMPANY
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Société Bristol-Myers Squibb Company

Actions

BMY

US1101221083

Produits pharmaceutiques

Marché Fermé - Nyse
Autres places de cotation
 22:00:02 23/04/2024 		Varia. 5j. Varia. 1 janv.
48,99 USD -0,31 % Graphique intraday de Bristol-Myers Squibb Company +1,51 % -4,52 %
23/04 L'entreprise allemande Evotec nomme Christian Wojczewski au poste de directeur général RE
23/04 Les actions en mouvement : OVH, Novartis, SAP ... toutes les publications de résultats résumées ici ! Our Logo

Métier

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.

70,1% du CA est réalisé aux Etats-Unis.

Nombre d'employés: 34 100

Ventes par activité

USD en Millions2022Poids2023Poids Delta
Innovative Medicines
100,0 %
46 159 100,0 % 45 006 100,0 % -2,50 %

Ventes par région

USD en Millions2022Poids2023Poids Delta
United States
70,1 %
31 828 69,0 % 31 555 70,1 % -0,86 %
International
28,3 %
13 497 29,2 % 12 752 28,3 % -5,52 %
Other
1,6 %
834 1,8 % 699 1,6 % -16,19 %

Dirigeants

Dirigeants TitreAgeDepuis
Christopher Boerner CEO
 Chief Executive Officer 53 01/02/15
David Elkins DFI
 Director of Finance/CFO 55 20/11/19
Greg Meyers CTO
 Chief Tech/Sci/R&D Officer - -
Kimberly McCutcheon Jablonski CMP
 Compliance Officer - 01/01/03
Estelle Vester-Blokland CTO
 Chief Tech/Sci/R&D Officer - -
Samit Hirawat CTO
 Chief Tech/Sci/R&D Officer 55 01/01/19
Robert Plenge CTO
 Chief Tech/Sci/R&D Officer 53 01/11/19
Laura Hortas IRO
 Public Communications Contact - -
Cynthia Piccirillo PRN
 Corporate Officer/Principal - -
Cari Gallman PRN
 Corporate Officer/Principal - -

Administrateurs

Administrateurs TitreAgeDepuis
Phyllis Yale BRD
 Director/Board Member 66 20/11/19
Peter Arduini BRD
 Director/Board Member 59 01/04/16
Derica Rice BRD
 Director/Board Member 59 01/09/20
Paula Price BRD
 Director/Board Member 62 01/09/20
Gerald Storch BRD
 Director/Board Member 67 24/01/12
Theodore Samuels BRD
 Director/Board Member 69 21/02/17
David Elkins DFI
 Director of Finance/CFO 55 20/11/19
Christopher Boerner CEO
 Chief Executive Officer 53 01/02/15
Julia Haller BRD
 Director/Board Member 69 20/11/19
Manuel Hidalgo Medina BRD
 Director/Board Member 56 01/06/21

Classe d'actions

VoteNombreFlottantAutocontrôleFlottant Total
Action A 1 2 928 758 715 2 024 582 731 ( 69,13 %) 902 000 000 ( 30,80 %) 69,13 %

Actionnaires

NomActions%Valorisation
Vanguard Fiduciary Trust Co.
9,799 %
198 159 772 9,799 % 10 746 M $
BlackRock Advisors LLC
6,437 %
130 159 802 6,437 % 7 059 M $
JPMorgan Investment Management, Inc.
4,436 %
89 694 867 4,436 % 4 864 M $
STATE STREET CORPORATION
4,423 %
89 446 206 4,423 % 4 851 M $
Capital Research & Management Co. (International Investors)
3,043 %
61 528 492 3,043 % 3 337 M $
Fidelity Management & Research Co. LLC
2,107 %
42 604 966 2,107 % 2 310 M $
Geode Capital Management LLC
1,962 %
39 677 105 1,962 % 2 152 M $
BlackRock Life Ltd.
1,596 %
32 274 031 1,596 % 1 750 M $
Norges Bank (13F)
1,504 %
30 413 639 1,504 % 1 649 M $
Eaton Vance Management
1,452 %
29 362 744 1,452 % 1 592 M $
NomActions%Valorisation
Bram Bradesco Asset Management S/A DTVM
0,000243 %
4 921 0,000243 % 256 847 $
NomActions%Valorisation
Transcend Wealth Collective LLC
-
117 775 - 6 478 $
FourWorld Capital Management LLC
-
100 000 - 5 500 $
Davenport & Co. LLC
-
83 970 - 4 618 $
FIFTH THIRD BANCORP
-
20 000 - 1 100 $
Private Advisor Group LLC
-
15 000 - 825 $
Paradigm Financial Partners LLC
-
10 000 - 550 $
Northwestern Mutual Wealth Management Co.
-
242 - 13 $
OAKWORTH CAPITAL INC.
-
125 - 7 $

Participations

NomActions%Valorisation
AVIDITY BIOSCIENCES, INC.
6,37%
 5 075 304 6,37% 129 521 758 $
KURA ONCOLOGY, INC.
1,80%
 1 370 171 1,80% 29 225 747 $
UNIQURE N.V.
4,99%
 2 388 108 4,99% 12 418 162 $
COMPUGEN LTD.
5,31%
 4 757 058 5,31% 12 273 210 $
CELULARITY INC.
5,49%
 1 195 327 5,49% 6 251 560 $

Coordonnées société

Bristol Myers Squibb Co.

Route 206 & Province Line Road

08543, Princeton

+609 252 4621

http://www.bms.com
Adresse Bristol-Myers Squibb Company(BMY)

Sociétés du groupe

NomCatégorie et Secteur
Bristol-Myers Squibb Pharmaceuticals Ltd.
Logo Bristol-Myers Squibb Pharmaceuticals Ltd.

Bristol-Myers Squibb Pharmaceuticals Ltd.

Pharmaceuticals: MajorHealth Technology

Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK.

Pharmaceuticals: Major
Celgene Alpine Investment Co. LLC
Bristol-Myers Squibb SARL
Logo Bristol-Myers Squibb SARL

Bristol-Myers Squibb SARL

Medical DistributorsDistribution Services

Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France.

Medical Distributors
Bristol-Myers Squibb Holdings Ireland Unlimited Co.
Logo Bristol-Myers Squibb Holdings Ireland Unlimited Co.

Bristol-Myers Squibb Holdings Ireland Unlimited Co.

Pharmaceuticals: MajorHealth Technology

Bristol-Myers Squibb Holdings Ireland Unlimited Co., a subsidiary of Bristol Myers Squibb Co., is a company headquartered in Ireland that operates as a holding company which develops medicines for serious diseases.

Pharmaceuticals: Major
Bristol-Myers Squibb Australia Pty Ltd.
Logo Bristol-Myers Squibb Australia Pty Ltd.

Bristol-Myers Squibb Australia Pty Ltd.

Pharmaceuticals: MajorHealth Technology

Bristol-Myers Squibb Australia Pty Ltd. is a biopharmaceutical company that researches, develops and markets medicines for serious diseases. The company was founded in 1930 and is headquartered in Noble Park North, Australia.

Pharmaceuticals: Major
Bristol-Myers Squibb (Finland) Oy Ab
Logo Bristol-Myers Squibb (Finland) Oy Ab

Bristol-Myers Squibb (Finland) Oy Ab

Pharmaceuticals: GenericHealth Technology

Part of Bristol Myers Squibb Co., Bristol-Myers Squibb (Finland) Oy Ab is a Finnish pharmaceutical manufacturing company. The private company is based in Vantaa, Finland. The company was founded in 1974. Simone Böhrer has been the CEO of the company since 2020.

Pharmaceuticals: Generic
Bristol-Myers Squibb Belgium SA
Logo Bristol-Myers Squibb Belgium SA

Bristol-Myers Squibb Belgium SA

Pharmaceuticals: MajorHealth Technology

Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Belgium SA develops, manufactures and distributes medicines. The private company is based in Watermael-Boitsfor, Belgium. The CEO of the Belgian company is Paul Lacante.

Pharmaceuticals: Major
Bristol-Myers Squibb de México S de RL de CV
Logo Bristol-Myers Squibb de México S de RL de CV

Bristol-Myers Squibb de México S de RL de CV

Pharmaceuticals: MajorHealth Technology

Part of Bristol Myers Squibb Co., Bristol-Myers Squibb de México S de RL de CV is a Mexican company that manufactures and supplies pharmaceutical and nutritional products. The private company is located in Mexico.

Pharmaceuticals: Major
Bristol-Myers Squibb AB
Logo Bristol-Myers Squibb AB

Bristol-Myers Squibb AB

Medical DistributorsDistribution Services

Part of Bristol Myers Squibb Co., Bristol-Myers Squibb AB is a private company that wholesales medical equipment and pharmacy. The company is based in Solna, Sweden.

Medical Distributors

Secteur

Santé
Recherche pharmaceutique et médicale
Produits pharmaceutiques
Produits pharmaceutiques
Pharmacies - Autres

Ventes par région

Notations pour Bristol-Myers Squibb Company

Note Trading
Note Investissement
ESG Refinitiv
B
Plus de notations

Consensus des Analystes

Vente
Consensus
Achat
Recommandation moyenne
CONSERVER
Nombre d'Analystes
27
Dernier Cours de Cloture
49,14 USD
Objectif de cours Moyen
56,2 USD
Ecart / Objectif Moyen
+14,36 %
Consensus

Révisions de BNA

Révisions des Estimations

Bénéfices trimestriels - Taux de surprise

Agenda de la société

Secteur Pharmacies - Autres

Varia. 1 janv. Capi.
BRISTOL-MYERS SQUIBB COMPANY Action Bristol-Myers Squibb Company
-4,52 % 99,59 Md
ELI LILLY AND COMPANY Action Eli Lilly and Company
+27,92 % 659 Md
NOVO NORDISK A/S Action Novo Nordisk A/S
+27,68 % 557 Md
JOHNSON & JOHNSON Action Johnson & Johnson
-4,59 % 359 Md
MERCK & CO., INC. Action Merck & Co., Inc.
+16,38 % 322 Md
ABBVIE INC. Action AbbVie Inc.
+9,39 % 297 Md
ASTRAZENECA PLC Action AstraZeneca PLC
+6,30 % 215 Md
NOVARTIS AG Action Novartis AG
+4,80 % 210 Md
ROCHE HOLDING AG Action Roche Holding AG
-6,05 % 200 Md
PFIZER, INC. Action Pfizer, Inc.
-8,58 % 149 Md
Pharmacies - Autres
  1. Bourse
  2. Actions
  3. Action BMY
  4. Société Bristol-Myers Squibb Company